Taken together, our results suggest that pharmacological modulation of NAD+ via the action of KL1333 on NQO1 improves energy balance, decreases oxidative stress, and restores mitochondrial functions and could be used to relieve the deleterious effects of mitochondrial diseases. Here, NQO1 is linked to inborn mitochondrial metabolism disorder.